160 related articles for article (PubMed ID: 15180198)
1. Factor V Leiden mutation in pregnancy.
Cohen SM
J Obstet Gynecol Neonatal Nurs; 2004; 33(3):348-53. PubMed ID: 15180198
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden: a review of the literature.
Ament L
J Perinat Neonatal Nurs; 2003; 17(3):190-5. PubMed ID: 12959480
[TBL] [Abstract][Full Text] [Related]
3. [Factor V Leiden mutation and pregnancy complications].
Abraitis V; Mongirdiene A; Mockeviciene A
Medicina (Kaunas); 2003; 39(9):823-9. PubMed ID: 14515043
[TBL] [Abstract][Full Text] [Related]
4. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
Simkova M; Simko F; Kovacs L
Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
[TBL] [Abstract][Full Text] [Related]
5. The impact of the factor V Leiden mutation on pregnancy.
Spina V; Aleandri V; Morini F
Hum Reprod Update; 2000; 6(3):301-6. PubMed ID: 10874575
[TBL] [Abstract][Full Text] [Related]
6. [Factor V Leiden mutation. Successful outcome of a pregnancy after heparin therapy].
Mazzarella CR; Del Bianco A; Pietropaolo F
Minerva Ginecol; 2003 Feb; 55(1):81-5. PubMed ID: 12598848
[TBL] [Abstract][Full Text] [Related]
7. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
9. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
Herman M; Djelmis J; Troselj Z; Ivanisević M
Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
[TBL] [Abstract][Full Text] [Related]
10. [Adrenal vein thrombosis during pregnancy].
Schmitt C; Debord MP; Grange C; Ben Cheikh A; Krauth JP; Dupuis O; Golfier F; Raudrant D
J Gynecol Obstet Biol Reprod (Paris); 2010 Feb; 39(1):68-71. PubMed ID: 19896780
[TBL] [Abstract][Full Text] [Related]
11. Factor V Leiden as a common genetic risk factor for venous thromboembolism.
Horne MK; McCloskey DJ
J Nurs Scholarsh; 2006; 38(1):19-25. PubMed ID: 16579319
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden: impact on infusion nursing practice.
Weinstein SM
J Infus Nurs; 2009; 32(4):219-23. PubMed ID: 19606001
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
Couto E; Nomura ML; Barini R; Pinto e Silva JL
Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
[TBL] [Abstract][Full Text] [Related]
14. Obstetric implications of activated protein C resistance and factor V Leiden mutation.
Gherman RB; Goodwin TM
Obstet Gynecol Surv; 2000 Feb; 55(2):117-22. PubMed ID: 10674255
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden mutation: a nursing perspective.
Page MJ
J Vasc Nurs; 1998 Dec; 16(4):73-7. PubMed ID: 10085870
[TBL] [Abstract][Full Text] [Related]
16. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation.
Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226
[TBL] [Abstract][Full Text] [Related]
17. The effect of factor V Leiden carriage on maternal and fetal health.
Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
[TBL] [Abstract][Full Text] [Related]
18. Obstetric implications of the factor V leiden mutation: a review.
Bloomenthal D; Delisle MF; Tessier F; Tsang P
Am J Perinatol; 2002 Jan; 19(1):37-47. PubMed ID: 11857095
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
DeSancho MT; Berlus N; Christos PJ; Rand J
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
Rodeghiero F; Tosetto A
Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
